Forecast: Antihypertensive Medicine Sales in New Zealand

New Zealand Antihypertensive Medicine Sales is set to reach $2.2 Million by 2026 from $2.2 Million, is expected to be up 4.1% per year. Italy, Spain and Australia respectively were numbers 2, 3 and 4 in this ranking.